BiotechTube
Mirror Biologics

Mirror Biologics

San Diego, United States· Est.
mirrorbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

Founded in 2018 and based in San Diego, Mirror Biologics is a private, pre-clinical stage biotech focused on autoimmune and inflammatory conditions. The company's core strategy revolves around its proprietary antibody engineering technology to design next-generation biologics. As a typical early-stage biotech, it is pre-revenue and likely funded by venture capital. Its success hinges on advancing its platform and pipeline candidates into clinical development to address significant unmet medical needs.

Autoimmune DiseasesInflammatory Diseases

Technology Platform

Proprietary antibody engineering platform for discovering and optimizing novel biologic therapies.

Funding History

1
Total raised:$3M
Seed$3M

Opportunities

The large and growing global market for autoimmune therapies presents a significant commercial opportunity.
A successfully validated platform could generate multiple drug candidates and enable lucrative partnerships or out-licensing deals.
Advances in biologics manufacturing and delivery may further enhance the value proposition of novel engineered antibodies.

Risk Factors

High scientific risk that the platform will not yield clinically differentiated candidates.
Intense competition from large pharma and other biotechs with substantial resources.
Dependence on external capital in a potentially challenging financing environment for early-stage life sciences companies.

Competitive Landscape

Mirror Biologics competes in a crowded field with major players like AbbVie, Johnson & Johnson, Amgen, and numerous agile biotechs (e.g., Alpine Immune Sciences, Immunovant). Differentiation requires demonstrating clear advantages in efficacy, safety, dosing, or patient population over existing anti-cytokine and immunomodulatory therapies.

More companies in Biologics / Biosimilars →More companies in United States →